Update: 16.04.2024
Last week: 14 week 2024 (01.04.2024 - 07.04.2024)
Last full month: March 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 444 | 14.8% | 10.7% | 0.9 | 18 916 196 | 14.0% | 9.1% | 0.8 | 4.7% |
| MoM | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| YTD | 98 687 | 23.1% | 10.8% | 2.2 | 221 684 572 | 54.4% | 9.3% | 2.1 | -2.3% |
| MAT | 359 370 | 32.9% | 9.7% | 1.7 | 734 908 323 | 48.2% | 8.2% | 1.4 | 9.6% |
| BRAINMAX | |||||||||
| WoW | 1 157 | 6.7% | 100.0% | 0 | 4 127 933 | 5.8% | 100.0% | 0 | 6.7% |
| MoM | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| YTD | 14 083 | 57.2% | 100.0% | 0 | 50 762 121 | 67.8% | 100.0% | 0 | 57.2% |
| MAT | 51 776 | 170.4% | 100.0% | NA | 181 513 581 | 188.0% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 18 831 | 2.2% | 45.7% | 0 | 58 479 729 | 2.5% | 36.8% | 0.1 | 2.3% |
| MoM | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| YTD | 234 231 | 2.1% | 44.2% | 2.1 | 747 552 380 | 8.0% | 36.1% | -2.2 | -2.7% |
| MAT | 873 890 | 19.1% | 45.5% | 2.1 | 2 746 759 776 | 28.1% | 39.0% | 0.9 | 13.5% |
| MIGRENIUM | |||||||||
| WoW | 15 189 | 33.2% | 0.7% | 0.2 | 4 699 571 | 32.8% | 0.9% | 0.2 | 0.0% |
| MoM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| YTD | 170 834 | -0.6% | 0.5% | -0.1 | 48 952 795 | 58.3% | 0.7% | 0.1 | 20.8% |
| MAT | 640 577 | 8.5% | 0.5% | 0 | 140 690 891 | 31.5% | 0.5% | 0 | 16.3% |
| MODELAX-N | |||||||||
| WoW | 33 176 | -12.3% | 24.8% | -3 | 13 938 308 | -11.8% | 15.9% | -2 | -1.7% |
| MoM | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| YTD | 447 174 | 60.5% | 23.6% | 6 | 183 059 212 | 107.6% | 14.7% | 4.6 | 19.8% |
| MAT | 1 336 623 | 112.1% | 20.3% | 8.4 | 477 681 051 | 130.6% | 11.7% | 4.9 | 24.8% |
| REDUXIN | |||||||||
| WoW | 13 264 | 2.9% | 32.2% | 0.2 | 73 480 953 | 2.6% | 46.2% | 0.1 | 2.3% |
| MoM | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| YTD | 176 065 | -8.0% | 33.2% | -1.9 | 960 123 617 | 23.6% | 46.4% | 3.4 | -2.7% |
| MAT | 622 518 | 2.5% | 32.4% | -3.5 | 3 056 177 832 | 21.5% | 43.4% | -1.3 | 13.5% |
| REDUXIN FORTE | |||||||||
| WoW | 3 505 | 5.4% | 8.5% | 0.2 | 14 837 422 | 3.4% | 9.3% | 0.1 | 2.3% |
| MoM | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| YTD | 46 113 | 6.5% | 8.7% | 0.8 | 202 257 673 | 25.7% | 9.8% | 0.9 | -2.7% |
| MAT | 168 829 | 29.9% | 8.8% | 1.1 | 694 916 840 | 41.2% | 9.9% | 1.1 | 13.5% |
| SALVISAR | |||||||||
| WoW | 11 994 | -1.0% | 1.5% | -0.1 | 4 726 986 | -2.5% | 1.3% | -0.1 | 2.7% |
| MoM | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
| YTD | 132 905 | -13.0% | 1.3% | -0.3 | 50 153 034 | 1.9% | 1.1% | -0.2 | 6.9% |
| MAT | 478 570 | -20.8% | 1.2% | -0.4 | 164 690 420 | -19.9% | 1.0% | -0.4 | 8.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 98 687 | 23.1% | 10.8% | 2.2 | 221 684 572 | 54.4% | 9.3% | 2.1 | -2.3% |
| BRAINMAX | 14 083 | 57.2% | 100.0% | 0 | 50 762 121 | 67.8% | 100.0% | 0 | 57.2% |
| GOLDLINE PLUS | 234 231 | 2.1% | 44.2% | 2.1 | 747 552 380 | 8.0% | 36.1% | -2.2 | -2.7% |
| MIGRENIUM | 170 834 | -0.6% | 0.5% | -0.1 | 48 952 795 | 58.3% | 0.7% | 0.1 | 20.8% |
| MODELAX-N | 447 174 | 60.5% | 23.6% | 6 | 183 059 212 | 107.6% | 14.7% | 4.6 | 19.8% |
| REDUXIN CAPS | 176 065 | -8.0% | 33.2% | -1.9 | 960 123 617 | 23.6% | 46.4% | 3.4 | -2.7% |
| REDUXIN FORTE | 46 113 | 6.5% | 8.7% | 0.8 | 202 257 673 | 25.7% | 9.8% | 0.9 | -2.7% |
| SALVISAR | 132 905 | -13.0% | 1.3% | -0.3 | 50 153 034 | 1.9% | 1.1% | -0.2 | 6.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 359 370 | 32.9% | 9.7% | 1.7 | 734 908 323 | 48.2% | 8.2% | 1.4 | 9.6% |
| BRAINMAX | 51 776 | 170.4% | 100.0% | NA | 181 513 581 | 188.0% | 100.0% | NA | NA |
| GOLDLINE PLUS | 873 890 | 19.1% | 45.5% | 2.1 | 2 746 759 776 | 28.1% | 39.0% | 0.9 | 13.5% |
| MIGRENIUM | 640 577 | 8.5% | 0.5% | 0 | 140 690 891 | 31.5% | 0.5% | 0 | 16.3% |
| MODELAX-N | 1 336 623 | 112.1% | 20.3% | 8.4 | 477 681 051 | 130.6% | 11.7% | 4.9 | 24.8% |
| REDUXIN CAPS | 622 518 | 2.5% | 32.4% | -3.5 | 3 056 177 832 | 21.5% | 43.4% | -1.3 | 13.5% |
| REDUXIN FORTE | 168 829 | 29.9% | 8.8% | 1.1 | 694 916 840 | 41.2% | 9.9% | 1.1 | 13.5% |
| SALVISAR | 478 570 | -20.8% | 1.2% | -0.4 | 164 690 420 | -19.9% | 1.0% | -0.4 | 8.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 444 | 14.8% | 10.7% | 0.9 | 18 916 196 | 14.0% | 9.1% | 0.8 | 4.7% |
| BRAINMAX | 1 157 | 6.7% | 100.0% | 0 | 4 127 933 | 5.8% | 100.0% | 0 | 6.7% |
| GOLDLINE PLUS | 18 831 | 2.2% | 45.7% | 0 | 58 479 729 | 2.5% | 36.8% | 0.1 | 2.3% |
| MIGRENIUM | 15 189 | 33.2% | 0.7% | 0.2 | 4 699 571 | 32.8% | 0.9% | 0.2 | 0.0% |
| MODELAX-N | 33 176 | -12.3% | 24.8% | -3 | 13 938 308 | -11.8% | 15.9% | -2 | -1.7% |
| REDUXIN CAPS | 13 264 | 2.9% | 32.2% | 0.2 | 73 480 953 | 2.6% | 46.2% | 0.1 | 2.3% |
| REDUXIN FORTE | 3 505 | 5.4% | 8.5% | 0.2 | 14 837 422 | 3.4% | 9.3% | 0.1 | 2.3% |
| SALVISAR | 11 994 | -1.0% | 1.5% | -0.1 | 4 726 986 | -2.5% | 1.3% | -0.1 | 2.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 34 128 | 17.0% | 10.5% | -0.5 | 76 805 654 | 16.8% | 9.0% | -0.6 | 23.0% |
| BRAINMAX | 4 695 | 18.9% | 100.0% | 0 | 17 055 157 | 18.5% | 100.0% | 0 | 21.5% |
| GOLDLINE PLUS | 80 084 | 17.2% | 44.7% | 0.9 | 251 582 555 | 15.7% | 36.1% | 0.2 | 14.8% |
| MIGRENIUM | 52 817 | -0.4% | 0.5% | 0 | 16 070 490 | 6.5% | 0.7% | 0 | 8.6% |
| MODELAX-N | 164 685 | 26.9% | 27.3% | 4.3 | 68 795 771 | 29.7% | 17.5% | 3.3 | 6.8% |
| REDUXIN CAPS | 58 968 | 14.9% | 32.9% | 0 | 324 783 811 | 17.2% | 46.6% | 0.9 | 14.8% |
| REDUXIN FORTE | 15 469 | 9.3% | 8.6% | -0.4 | 66 626 856 | 4.4% | 9.6% | -1 | 14.8% |
| SALVISAR | 51 767 | 46.5% | 1.5% | 0.4 | 20 518 388 | 55.8% | 1.4% | 0.4 | 8.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs